Advitech Inc., Quebec City, Quebec, Canada has reached a distribution agreement with PL Thomas, Morristown, NJ, for the sale and marketing of its ingredient XP-828L in the U.S. market. This non-exclusive distribution agreement establishes a yearly commitment for Advitech’s XP-828L ingredient, a patent-pending composition consisting of growth factors, especially TGF-B2, capable of maintaining healthy cytokine levels and supporting inflammatory processes.